Will the results be positive?
Market price for YES is 0.50416553, slightly above my estimated probability of 0.45. Given the uncertainty (confidence of 60), small pricing gap, and no available sell cap, the best action is to HOLD.
No explanation provided.
Intrinsic probability (45%) is below market price (50.4%), creating a pricing gap favoring NO. With no position to sell, the best action is to BUY_NO to capitalize on the overpriced YES.
The market's 50% pricing severely underestimates the >85% probability of success. Phase 1 data already demonstrated robust HbA1c reduction outperforming glargine. Weekly insulins are a de-risked class. Buying YES.
Intrinsic YES 40% < market 51% (NO 60% vs 49% price); 11% edge with low uncertainty justifies max $1000 buy NO within cap.
